Diepalrestat choline

N/A

Report date: 2024/10/16 17:38:16

Base Information

Drug NameDiepalrestat choline
Drug Alias NameCholine cocrystal of epalrestatCholine diepalrestatNM-IA-001BNV-222
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAldose reductase inhibitors
TargetsAldose reductase
Therapy Area/IndicationsDiabetic peripheral neuropathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBionevia Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeuromaxbionevia
Active IndicationsN/A
Inactive IndicationsDiabetic peripheral neuropathy

Other Information

ATC CodeN/A
Related LinksN/A